Clinical Trials on Ductal Breast Carcinoma in Situ

Total 36476 results

Henan Cancer Hospital

Recruiting

A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

HER2 Low Breast Carcinoma

China
Tata Medical Center

Completed

Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer (HYPORT)

Carcinoma Breast Stage IV

India
University College, London

Unknown

TARGeted Intraoperative radioTherapy (TARGIT) Registry Database (TARGIT R)

Early-Stage Breast Carcinoma

United Kingdom
Centre Henri Becquerel

Unknown

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (EPIC)

Early Stage Breast Carcinoma

France
National Cancer Institute, Thailand
Vichaiyut Hospital

Withdrawn

Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.

Carcinoma Breast Stage IV

Thailand
University of Magdeburg
Boehringer Ingelheim

Terminated

BIBW 2992 (Afatinib) and Vinorelbine

Carcinoma Breast Stage IV

Germany
Emory University
National Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)

Completed

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis (ASPIRE)

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Metastatic Breast Carcinoma

United States
Merck Sharp & Dohme LLC

Completed

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Cervical Cancer | Cervical Intraepithelial Neoplasia | Adenocarcinoma in Situ
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Advanced HR+ HER2 Negative Breast Carcinoma
Tianjin Medical University Cancer Institute and...

Recruiting

H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study

Advanced HR+ HER2 Negative Breast Carcinoma

China
M.D. Anderson Cancer Center

Completed

Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

Breast Carcinoma | Invasive Breast Carcinoma

United States
Breast Cancer Trials, Australia and New Zealand
ETOP IBCSG Partners Foundation; Breast International Group

Recruiting

EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT)

Early Stage Breast Carcinoma

Taiwan, Australia, Spain, New Zealand, Ireland, Italy, Argentina, Switzerland, Chile
University Hospital Schleswig-Holstein
University of Luebeck

Active, not recruiting

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer (HYPOSIB)

Early-Stage Breast Carcinoma

Germany
European Institute of Oncology

Active, not recruiting

Sentinel Node Vs Observation After Axillary Ultra-souND (SOUND)

Early Stage Breast Carcinoma

Italy, Chile, Spain, Switzerland
Kliniken Essen-Mitte
German Breast Group

Completed

Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer

Early-Stage Breast Carcinoma

Germany, Switzerland
Jules Bordet Institute

Completed

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Carcinoma Breast Stage IV

Belgium
Assiut University

Recruiting

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Use of Zoledronic Acid in Breast Cancer

Egypt
Fudan University

Recruiting

Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy (Castle06(BC))

Metastatic Breast Cancer in the Liver

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy

Invasive Breast Carcinoma | HER2/Neu Negative | Bilateral Breast Carcinoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Breast Carcinoma | Colorectal Carcinoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Suspended

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Metastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma

United States
National Cancer Center, Korea
Seoul National University Hospital

Not yet recruiting

Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers (Dulastin)

Unresectable Pancreatic Cancer | Unresectable Biliary Tract Carcinoma | Unresectable Bile Duct Carcinoma
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Carcinoma Metastatic in Lymph Node | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Estrogen Receptor-Positive Breast Carcinoma

United States
Sun Yat-sen University

Terminated

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

Carcinoma Breast Stage IV

China
Centre Henri Becquerel

Completed

Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer (VOSETEP)

Infiltrating Ductal Carcinoma

France
Fudan University

Recruiting

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

Lung Adenocarcinoma | Frozen Section | Sublobar Resection

China
Roswell Park Cancer Institute

Completed

A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity

Cancer Survivor | Invasive Breast Carcinoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography

Healthy Subject | Female Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Suspended

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Metastatic Breast Carcinoma | Peritoneal Effusion

United States
National Cancer Institute (NCI)

Terminated

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | HER2-Positive Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Enrolling by invitation

Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Resectable Breast Carcinoma

United States
Azienda U.S.L. 1 di Massa e Carrara

Completed

RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLD (RAD2016)

Breast Cancer in Women Under 40 Years Old
Outcomes4Me
Massachusetts General Hospital

Unknown

Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients (FIONA)

Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Metastatic Breast Carcinoma

United States
Rhode Island Hospital
DUSA Pharmaceuticals, Inc.

Unknown

Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ

Squamous Cell Carcinoma
CG Oncology, Inc.

Terminated

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (BOND)

Carcinoma in Situ | Transitional Cell Carcinoma | Bladder Cancer | Carcinoma in Situ Concurrent With Papillary Tumors

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Study on the Correlation Between the Quantitative Parameters of Mr Mean Cell Size Imaging and the Histopathological Characteristics of Breast Cancer (OGSE)

Breast Carcinoma; Magnetic Resonance Imaging；OGSE

China
Mahdis Bayat

Completed

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

HER2 Low Breast Carcinoma
Celltrion
Nippon Kayaku Co., Ltd.

Completed

Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

HER2-positive Carcinoma of Breast

Italy, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
Karolinska University Hospital

Recruiting

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer (MIMIR-mTNBC)

Metastatic Triple-Negative Breast Carcinoma

Sweden
St. Joseph Hospital of Orange

Active, not recruiting

Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT)

Invasive Lobular and Ductal Carcinoma

United States
National Cancer Institute (NCI)

Recruiting

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Malignant Solid Neoplasm | Breast Carcinoma | NUT Carcinoma

United States
Peking University Cancer Hospital & Institute

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma

Collecting Duct Carcinoma

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
The Netherlands Cancer Institute

Completed

Olaparib and Radiotherapy in Inoperable Breast Cancer

Locally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast Carcinoma

Netherlands
National Cancer Institute (NCI)

Recruiting

Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma

United States
Margaret Quinn Rosenzweig
Apollo Neuroscience, Inc.

Recruiting

Apollo Device for Metastatic Breast Cancer (MBC)

Fatigue | Metastatic Breast Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer

Women at Increased Risk for Developing Breast Carcinoma

United States
University College, London
European Union

Completed

PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional (PICTURE XS)

Early-Stage Breast Carcinoma

United Kingdom, Netherlands, Portugal

Clinical Trials on Ductal Breast Carcinoma in Situ

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations